All News

Experts say the clinical presentation of herpes zoster in pregnant women should be carefully monitored and reported for further assessment, especially if it is associated with other signs of COVID-19.

Research shows that closed-loop systems can increase time in range and reduce both hyperglycemia and hypoglycemia in youth and young adults.

The findings suggest that the prevalence of these conditions among cancer survivors is nearly 40% higher than that in the general population.

There are 3 more COVID-19 vaccines that are expected to become available in the United States in the coming months from AstraZeneca, Johnson & Johnson, and Novavax, with specific implications for each one.

First approved by the FDA in 1989 for 2 rare eye muscle disorders, onabotulinumtoxinA (Botox; Allergan) was the world’s first approved botulinum toxin type A treatment.

The product portfolio includes lamotrigine (ET-105), zonisamide (ET-104), and topiramate (ET-101). These medications are currently under review with the FDA.

A clinical trial of patients with COVID-19 at high risk for disease progression showed that a single intravenous infusion of bamlanivimab and etesevimab together significantly reduce COVID-19-related hospitalization and death.

Women whose tumors responded to estrogen treatment were found to benefit from hormone therapy, whereas those whose tumors did not respond experienced worsening disease.

Migraine attacks are the leading cause of disability in individuals younger than 50 years and predominantly affect women.

Four months after training, military personnel reported less stress and depressive symptoms as well as more satisfaction and resilience in their lives.

Pharmacists must develop professional behavior and a common professional identity that goes beyond their personal values and self-interests.

Across all of the nations studied, investigators found that the United States accounted for 58% of all prescription drug sales but just 24% of the volume.

The BTD designations for asciminib were based on the phase 3, multicenter, open-label, randomized ASCEMBL trial and a phase I trial that included patients with Ph+ CML, some of them harboring the T315I mutation.

The investigators said the undertreatment of coronary artery disease in women largely stems from a failure to recognize key differences in cardiovascular risk factors and symptoms in women.

Investigators are working to create a second generation of the vaccine, adapted to target variants with mutations similar to those found in South Africa.

Of 192 study participants who received Breyanzi, 73% achieved a response, including 54% who had minimal or no detectable lymphoma remaining following treatment and 19% who achieved a partial response.

In order to eradicate HIV, the researchers said increasing health coverage will be essential. Without that, HIV will continue to spread, and individuals will be unaware of their status.

The national advocacy organization for women pharmacists strengthens MJH’s position in the pharmacy industry.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week:

The report, developed by Thomas McAndrew, a computational scientist and faculty member at Lehigh University's College of Health, and colleagues, uses data from experts and trained forecasters, combining their predictions into a single consensus forecast.

The program educates patients on how to use the FreeStyle Libre 2 system as well as ways to positively impact their glucose levels through diet and fitness.

The FDA has granted an accelerated approval to umbralisib for the treatment of select patients with relapsed/refractory marginal zone lymphoma and relapsed/refractory follicular lymphoma.

The clinical trials analyzed were from the United Kingdom, Brazil, and South Africa, where COVID-19 variants are of significant concern.

In a recent congressional hearing, the NACDS submitted a statement underscoring the critical role of pharmacies, pharmacists, and pharmacy teams in the COVID-19 response and recovery efforts taking place across the country.

The investigational vaccine is compatible with standard vaccine distribution channels.

The diagnosis and management of neurologic conditions can be more complex when patients are at the extremes of age.

Cardiovascular health risks exacerbated by lifestyle changes caused by the pandemic will become an even more critical issue in coming years.

The results are from a public polling of more than 800 English-speaking adults nationwide in a study published in the journal Vaccine.